Právní předpis byl sestaven k datu 01.01.2014.
Zobrazené znění právního předpisu je účinné od 01.01.2014 do 30.09.2015.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
463
XXXXXXXX XXXXX
xx dne 18. prosince 2013
x xxxxxxxxx xxxxxxxxxx xxxxx
Xxxxx xxxxxxxx podle §44c xxxx. 1 xxxxxx x. 167/1998 Xx., x xxxxxxxxxx xxxxxxx x x xxxxx xxxxxxxxx dalších xxxxxx, xx xxxxx zákona x. 273/2013 Xx.:
§1
Xxxx nařízení stanoví
a) x příloze č. 1 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxxxx xxxxxx x xxxxxxxx látkách1) x
2. xxxxxxx omamných xxxxx, x xxxxx xx z xxxxxx xxxxxxx jejich zneužívání xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, nezbytné xxxxxxx xxxxxxxxx xxx xx xxxxxxx xxxxxxxx x xxxxxxxxx, xxxx xx z tohoto xxxxxx nutné xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx xxxx xxxxxx xxxxx byly xxxxxxxx x xxxxxxx xxxxx xx xxxxxx nebo xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx x xxxxxx dolního xxxx xx xxxxxxx xxxxxxx xxxx,
(xxxx jen "xxxxxx x. 1 xxxxxxxx xxxxx"),
x) x příloze č. 2 x tomuto xxxxxxxx xxxxxx
1. omamných látek xxxxxxxxxx xx Xxxxxxx XX xxxxx Jednotné xxxxxx x xxxxxxxx xxxxxxx x
2. dalších xxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, xxx xxxxxx přípravky obsahující xxxx xxxxxx xxxxx xxxx vydávány x xxxxxxx xx recept xxxx xxxxxxx bez xxxxxxxx modrým pruhem,
(dále xxx "seznam č. 2 xxxxxxxx xxxxx"),
x) x příloze č. 3 k xxxxxx nařízení xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx IV xxxxx Xxxxxxxx xxxxxx x xxxxxxxx látkách x
2. xxxxxxx xxxxxxxx xxxxx, u xxxxx xx x důvodu xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx zdraví, xxxxx xxxxxxxxxx, aby xxxxx x xxxxxxxxx obsahující xxxx omamné xxxxx xxxx používány xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx v xxxxxxxx x xxxxxxxxx,
(xxxx jen "xxxxxx x. 3 xxxxxxxx xxxxx"),
x) x příloze č. 4 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx I xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) x
2. dalších xxxxxxxxxxxxxx xxxxx, x xxxxx xx z xxxxxx xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují zdraví, xxxxx zabezpečit, xxx xxxxx x xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxxxxx xxxxx xxxx používány xxxxx k xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx x xxxxxxxx k xxxxxxxxx,
(xxxx xxx "xxxxxx x. 4 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx látek zařazených xx Xxxxxxx XX xxxxx Úmluvy o xxxxxxxxxxxxxx látkách x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x nimiž xx x důvodu rozsahu xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx jen na xxxxxxx xxxxxxxx x xxxxxxxxx, xxxx xx x tohoto důvodu xxxxx xxxxxxxxxx, aby xxxxxx přípravky xxxxxxxxxx xxxx psychotropní látky xxxx xxxxxxxx x xxxxxxx pouze xx xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx rohu do xxxxxxx xxxxxxx rohu,
(dále xxx "xxxxxx č. 5 xxxxxxxxxxxxxx xxxxx"),
x) x příloze č. 6 x xxxxxx nařízení xxxxxx xxxxxxxxxxxxxx látek xxxxxxxxxx xx Seznamu XXX xxxxx Úmluvy x xxxxxxxxxxxxxx xxxxxxx,
x) x příloze č. 7 k xxxxxx xxxxxxxx xxxxxx
1. psychotropních xxxxx zařazených do Xxxxxxx XX podle Xxxxxx x xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx je z xxxxxx rozsahu jejich xxxxxxxxxx anebo xxxxx, xx bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx xxxx xxxxx xxxx xxxxxxxx x xxxxxxx xx recept xxxx xxxxxxx bez označení xxxxxx pruhem,
(dále jen "xxxxxx x. 7 xxxxxxxxxxxxxx xxxxx"), x
x) x příloze č. 8 k xxxxxx nařízení seznam xxxxxxxxx xxxxxxxxxx do Xxxxxxx XXX xxxxx Xxxxxxxx xxxxxx o xxxxxxxx xxxxxxx,
(xxxx jen "xxxxxx x. 8 xxxxxxxxx xxxxxxxxx").
§2
Xxxx xxxxxxxx xxxx xxxxxxxx v souladu xx xxxxxxxx Evropského xxxxxxxxxx a Rady 98/34/ES ze xxx 22. června 1998 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx v xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxxx a xxxxxxxx pro služby xxxxxxxxxx xxxxxxxxxxx, x xxxxxxx xxxxx.
§3
Xxxx xxxxxxxx xxxxxx xxxxxxxxx xxxx 1. xxxxx 2014.
Xxxxxxx č. 1 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 1 xxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-ethenomofinan-3-yl-acetán |
|
|
AcelyI-alfa-methylfentanyl |
(RS)-N-[1-(2-fenyI-2-methylethyl)-4-piperidyl]acetanilid |
|
|
AcetyImethadol |
(3RS)-6-(dirnethylamino)-4,4-difenylheptan-3-yl-acetát |
|
|
Alfacetylmethadol |
(3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-yl-acetát |
|
|
Alfameprodin |
(3RS,4Rs)-3-elhyl-4-fenyl-1-methylpiperidin-4-yl-propanoát |
|
|
Alfarnethadol |
(3R,6R)-6-(dimethylamino)-4,4-difenylheptan-3-ol |
|
|
Alfa-methylfentanyl |
N-{1-[(1RS)-2-fenyl-1-methylethyl]piperidin-4-yl}propananilid |
|
|
Alfa-methylthiofentanyl |
N-{1-[(1RS)-1-methyl-2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
AIfaprodin |
(3R,4SR)-4-fenyl-1,3-dimethylpiperidin-4-yI-propanoát |
|
|
Alfentanil |
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl) xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
3-(xxxxxxXxxx)-4.5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
(3X,6X)-6-{xxxxxxxxxxxxx )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) xxxxxxxxxx]xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx- 6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (1X,2X,3X,5X)-3-xxxxxxx-8-xxxxxx-9-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, xxxx xxxxxx x deriváty, x xxxxxxx je xxxxx xxxxxx xxxxxxx x kokain |
|
|
Ethylmethylthiambuten |
N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin |
|
|
Etonitazen |
1-[2-(deethylamino)ethyl]-2-(4-ethoxybenzyl]-5-nitro-1H-benzimidazol |
|
|
Etoxeridin |
ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát |
|
|
Fenadaxon |
4,4-difenyl-6-morfolinoheptan-3-on |
|
|
Fenampromid |
N-(1-methyl-2-piperidinoethyl)propananilid |
|
|
Fenazocin |
(2RS,6R,11R)-3-fenethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano- 3-xxxxxxxxxx-8-xx |
|
|
Xxxxxxxxxx |
17-xxxxxxxXxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxX-4-xxxxX-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxXxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) amino]oxy}octová |
|
|
Koka - xxxx |
Xxxxxx list |
|
|
Kokain |
(1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyklo[3.2.1]oktan-2- xxxxxxxxxx |
|
|
Xxxxxxxxxx x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx alkaloidů získaný xxxxxxxxxxxxxx úpravou xxxxxxxx |
|
|
Xxxxxx xxxxxxx a xxxxxxxx |
Xxxxxxx x xxxxxxxx x xxxxxx |
|
|
Xxxxxx xxx xxxxxxx xxxxxxx |
xxxxxx xxxxxx k xxxxxxxx xxxxxxxx přípravků xx xxxxxxxxxxxxxxxx obsahem xxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx vyňat xx seznamu xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx |
|
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx uvedených x xxxx xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxx, xxxxxxxxxxx |
2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx methobromid |
4,5α-epoxy-3,6α-dihydroxy-17,17-dimethylmorfin-7-en-17-ium-bromid |
a jiné xxxxxxxx xxxxxxx xx xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxx xxxxxx-X-xxxxx (i xxxxxx-X-xxxxx) |
|
Xxxxxx-X-xxxx |
4,5α -xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
|
XxxxxxxxXxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
|
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxX |
|
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxx |
Xxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xxxxxx xxxxxx je xxxxx xxx X4 xxxx CH2 |
|
|
Oripavin |
4,5α-epoxy-6-methoxy-17-methylmorfina-6,8(14)-dien-3-ol |
|
|
Oxykodon |
(5R)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorfinan-6-on |
|
|
Oxymorfon |
(5R)-4,5-epoxy-3,14-dihydroxy-17-methylmorfinan-6-on |
|
|
Parafluorfentanyl |
N-(1-fenethyIpiperidin-4-yl)-4'-fluorpropanamilid |
|
|
Pheneridin |
ethyl-1-fenethyl-4-fenylpiperidin-4-karboxylát |
PEPAP |
|
Pethidin |
ethyl-4-fenyl-1-methylpiperidin-4-karboxylát |
|
|
Pethidin, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx B |
ethyl-4-fenylpiperidin-4-karboxylát |
|
|
Pethidin, xxxxxxxxxxx C |
kyselina 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxx-1-(3-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
1'-(3,3-xxxxxxx-3-xxxxxxxxxx-4'-xxxxxx-1,4'-xxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
4-xxxxx-1,3-xxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxxxxxX-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(9XX,13XX,14XX)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9XX,13XX,14XX)-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
xxxxxx-3-[4-(X-xxxxxxxxxxxxxxx)4-(xxxxxxxxxxxxxxx)]xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{4-(xxxxxxxxxxxxx)-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-[(1X,2X)-3-(xxxxxxxxxxxxx)-1-xxxxx-2-xxxxxxxxxxxx]xxxxx |
|
|
Xxxxxxx |
4,5α-xxxxx-3,6-xxxxxxxxx-17-xxxxxxxxxxxxxxx-6,8-xxxx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-3-xxxxxxx-17-xxxxxXxxxxxx-6-xx-6-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx omamných xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxx estery x ethery xxxxxxxx xxxxx xxxxxxxxx x xxxxx seznamu x xxxx xxxxxxxx xxxxx xxxxxxxxx v xxxxx xxxxxxx xxxxxx xxxx xxxxxxx, esterů x xxxxx ve všech xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Příloha x. 2 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 2 omamných xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx uvedených x xxxxx xxxxxxx, dále xxxx xxxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx, včetně xxxx xxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx xx xxxxx případech, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 3 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 3 omamných xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxx |
[5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx- 17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
|
|
Xxxxxxxxxxx |
1-[4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
|
|
Xxxxxx |
X xxxxxxxx xxxxxx pro xxxxxxx xxxxxxx uvedené x xxxxxxx x. 1 |
|
|
Xxxxxxxxxx x konopí |
Včetně xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx soli xxxxx xxxxxxxxx.
Xxxxxxx x. 4 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 4 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
XX-2201 |
[1-{5-xxxxxxxxxxx}-1X--xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
||
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
|
xx-XXXX |
1-(4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-{4-xxxx-2,5-xxxxxxxxxxxxxx}xxxxxx-2-xxxx |
|
|
Xxxxx-Xxxxxxxxx |
1-(8-xxxxxxxxxx[1,2-x']xxxxxxx-4-xx)xxxxxx 2-amin |
||
|
Butylen |
2-(methyIamino)-1-(3,4-(methylendioxy)fenyl)butan-1-on |
||
|
Joddimethoxyfenethylamin |
2C-1 |
(4-jod-2,5-dimethoxyfenethyl)amin |
|
|
Dimethoxyethyltriofen xxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxx xxxxxxxxx |
2X-X-7 |
[2,5-xxxxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxxxx]xxxx |
|
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
||
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-{2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X- benzo[c]chromen-1-ol |
|
|
Dimethyltriptamin |
DMT |
N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin |
|
|
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
||
|
Dimethoxyethylamfetamin |
DOET |
(2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin |
|
|
DOI |
1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin |
||
|
Eticyklidin |
PCE |
N-ethyl-1-fenylcyklohexylamin |
|
|
Etryptamin |
3-(2-aminobutyl)indol |
||
|
Flefedron |
1-(4-fluorfenyl)-2-(methylamino)propan-1-on |
||
|
4-FMA |
1-(4-fluofenyl)-N-methylpropan-2-amin |
||
|
JWH-018 |
(naftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
JWH-073 |
(1-butyl-1H-indol-3-yl)(naftalen-1-yl)rnethanon |
||
|
JWH-081 |
(4-methoxynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
JWH-122 |
(4-methylnaftalen-1-yl)(1-pentyI-1H-indol-3-yl)methanon |
||
|
JWH-200 |
[1-{2-morfolinoethyl)-1H-indol-3-yl](naftalen-1-yl)methanon |
||
|
JWH-250 |
2-(2-methoxyfel)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on |
||
|
JWH-398 |
(4-chlornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
Kathion |
(2S)-2-amino-1-fenylpropan-1-on |
||
|
(+)-Lysergid |
LSD, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
|
4-Xxxxxxxxxxxx |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
||
|
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
||
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
4-XXX |
2-[xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2xxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx ?? |
||
|
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxx-xxxxxx |
||
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
Xxxxxxxxxxxx |
XXX, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
|
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3 -xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxx[x]xxxxxxxxxx- 7-xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
XXXXX |
1-[3-(xxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
Δ6x(10x)-,Δ6x(7)-,Δ7-,Δ8-,Δ10-,Δ9(11)-xxxxxxxxxxxxxxxxxxxx a xxxxxx stereoizomery |
|
|
Trimethoxyamfetamin |
TMA |
(2RS)-1-(3,4,5-trimethoxyfenyl)propan-2-amin |
|
|
Trimethoxyamfetamin-2 |
TMA-2 |
(2RS)-1-(2,4,5-trimethoxyfenyl)propan-2-amin |
Včetně xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx, xx xx výslovné xxxxxxx, xxxxxxxxx x tomto xxxxxxx xx všech xxxxxxxxx, xxx tyto xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx a xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x tomto seznamu xx xxxxx xxxxxxxxx, xxx mohou xxxxxxxxx.
Příloha x. 5 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) xxxxx]xxxxxxxxx |
||
|
Xxxxxxxxxx |
(2X)-2-[(5X,6X,7X,14X)-17-(xxxxxxxxxxxxxxxxx)-4,5α-xxxxx-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx butan-2-ol |
||
|
Bromdimethoxyfenethyl amin |
2C-B |
(4-brom-2,5-dimethoxyfenethyl)amin |
|
|
Dexamfetamin |
(2S)-1-fenylpropan-2-amin |
||
|
Fencyklidin |
PCP |
1-(1-fenylcyklohexyl)piperidin |
|
|
Fenetylin |
7-(2-{[(2RS)-1-fenylpropan-2-yl]amino}ethyl)-1,3-dimethyl-7H- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-hydroxybutanová |
||
|
Levamfetamin |
(2RS)-1-fenylpropan-2-amin |
||
|
Levmetamfetamin |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
|
Meklochalon |
3-(2-chlorfenyl)-2-methyl-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metachalon |
2-rnethyl-3-(2-methylfenyl)-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metamfetamin |
(2S)-1-fenyl-N-methylpropan-2-amin |
||
|
Metamfetamin racemický |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
|
Methylfenidát |
methyl-(2RS)-2-fenyl-2-[(2RS)-piperidin-2-yl]acetát |
||
|
Sekobarbital |
kyselina 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxx stereoizomery |
např. (-)-xxxxx-Δ9-XXX |
|
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] xxxxxx-2xx |
Xxxxxx xxxx xxxxx xxxxxxxxx v této xxxxxxx xx xxxxx xxxxxxxxx, xxx existence xxxxxxxx xxxx xx xxxxx.
Xxxxxxx x. 6 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 6 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 5-allyl-5-isobutylbarbiturová |
||
|
Cyklobarbital |
kyselina 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- hexahydro-2,6-methano-3-benzazocin-8-ol |
||
|
Pentobarbital |
kyselina 5-xxxxx-5[(1XX)-1-xxxxxxxxxxx]xxxxxxxxxxx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx existence takových xxxx xx xxxxx.
Xxxxxxx x. 7 x xxxxxxxx vlády x. 463/2013 Sb.
Seznam x. 7 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx mezinárodní nechráněný xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X.[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx kyselina |
||
|
Benzfetamin |
(+)-N-benzyl-N-(2-fenyl-1-methylethyl)-N-methylamin |
||
|
Benzylpiperazin |
1-benzylpiperazin |
||
|
Bromazepam |
7-brom-5.(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Brotizolam |
2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a]diazepin |
||
|
Butobarbital |
5-butyl-5-ethylbarbiturová xxxxxxxx |
||
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3- xxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
(±)-1-xxxxx-2-[(2-xxxxxxxxx)xxxxx]xxxxxx |
||
|
Xxxxxxxx |
2-xxxxx-1,1-xxxxxxxxxxxxxxxxx |
||
|
XXxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
XXxxxxxxxxx |
7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx- 2-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx -6(5H)-on |
||
|
Chlordiazeproxid |
7-chlor-5-fenyl-2-(methylamono)-3H-1,4-benzodiazepin-4-oxid |
||
|
Kamazepam |
7-chIor-5-fenyl-1-methyl-2-oxo-1,3-dihydro-2H-1,4-benzodiazepin-3-yl-dimethyl xxxxxxxx |
||
|
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4] xxxxxxxxxxxx-4,7(6X)-xxxx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxx-2,4(3X,5X]-xxxx |
||
|
Xxxxxxxxxx |
5-{2-xxxxxxxxxX}-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx--2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X- xxxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2 -xx |
||
|
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2,1-α]-xxxxxxxx-5-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
|
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx kyselina |
||
|
Methyprylon |
3,3-diethyl-5-methylpiperidin-2,4-dion |
||
|
Midazolam |
8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazol[1,5-α][1,4]bezodiazepin |
||
|
Nimetazepam |
5-fenyI-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nitrazepam |
5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nordazepam |
7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazepalll |
7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazalant |
10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydroozazolo[3,2-d][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxx |
5-xxxxX-2-xxxxx-1,3 -oxazolidin-4-on |
||
|
Pinazepam |
7-cchlor-4-fenyl-1-(prop-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Pipradrol |
difenyI(2-piperidyl)methanol |
||
|
Prazepam |
7-chlor-1-(cyklopropylmethyl)-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Pyrovaleron |
(±)-1-(4-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
||
|
Sekbutabarbital |
5-ethyl-5-(1-rnethylpropropyl)barbiturová kyselina |
||
|
Temazepam |
(RS)-7-chlor-5-fenyl-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Tetrazepam |
7-chlor-5-(cyklohex-1-en-1-yl)-1-methyl-1,3-dihydro-2H-1,4-bezodiazepin-2-on |
||
|
Triazolamn |
8-chlor-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-α][1,4]benzodiazepin |
||
|
Vinylbital |
5-(1-methylbutyl)-5-vinylbarbiturová xxxxxxxx |
||
|
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxxx[1,2-α]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx látek xxxxxxxxx v této xxxxxxx xx xxxxx xxxxxxxxx, xxx existence xxxxxxxx xxxx je xxxxx.
Xxxxxxx x. 8 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 8 xxxxxxxxx xxxxxxxxx
|
Xxxxxxxxx obsahující: |
Podmínky: |
||
|
1) |
jednu z xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx obsahovat xxxxx xxxx xxxx xxxxxxx xxxxx (xxxxxxx xxxx omamných) x xxxxxxxx omamné xxxxx |
|
|
x) |
x xxxxx xxxxxxx, xxxxxxx, xxxxxx, čípku, xxxx. x xxxx lékové xxxxx xxxxx xxxxxxxxxx 100 xx, |
||
|
x) |
x roztoku xxxxx xxx xxxxxxxxxxx xxxxx xxx 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxx nesmí xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx 0,5 mg. |
|
b) |
Množství atropin-sulfátu xxxx xxx nejméně 5 % x xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxx, xxxxxx, xxxxx, popř. xxxx xxxxxx xxxxx. |
||
|
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx tabletě, xxxxxxx, xxxxxx, čípku, xxxx. v jiné xxxxxx formě 2,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx musí xxx xxxxxxx 1 % k xxxxxxxx xxxxxxxxxxxx v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, popř. x xxxx xxxxxx formě. |
||
|
4) |
dextroprapotyfen |
Množství xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx xxxxxxxxxx 135 xx v jedné xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. x xxxx xxxxxx xxxxx. |
||
|
x) |
x xxxxxxx nesmí xxx xxxxxxxxxxx vyšší než 2,5 %. |
||
|
Přípravek xxxxx xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx kokainu nesmí xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,2 %. |
|
b) |
Dále xxxxx xxxxxxxxx xxxxx xxxx xxxx xxxxxxx xxxxx (xxxxxxx však xxxxxxxx). |
||
|
Xxxxxx xxxxx x xxxxxxxxx xxxxxxxx xxxxx xxx xxxxxx získána xxxx x takovém xxxxxxxx, xxx xxxxxxxx veřejné xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx xxxxxx x xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx xxxxx xxx xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx xxxxxxxxxxxxxxx xxxxxx xxxxx xxx xxxxx xxx 10 %. |
||
|
c} |
Množství xxxxx xxxx xxxx xxxxxxx látek (xxxxxxx xxxx xxxxxxxxx) nesmí xxx xxxxx než 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx propiramu xxxxx xxxxxxxxxx 100 xx x jedné tabletě, xxxxxxx, xxxxxx, xxxxx, xxxx. v jiné Xxxxxx xxxxx. |
|
x) |
Xxxxxxxxx methylcelulosy x přípravku xxxx xxx xxxxxxx stejné xxxx vyšší xxx xxxxxxxxx. |
||
Xxxxxx xxxxxxxxxxxx vyrobených xxxxxxxxx, jejichž xxxxxx xxxxxx xx xxxxx xxx D4 xxxx XX2.
Xxxxxx xxxxxxx č. 463/2013 Xx. xxxxx xxxxxxxxx xxxx 1.1.2014.
Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxxxx xxxxxxx předpisem x.:
243/2015 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxx xxxxx č. 243/2015 Xx.
x xxxxxxxxx od 1.3.2017 s xxxxxxxx xxxxxxxxx ustanovení, xxxxx xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., kterým xx xxxx nařízení vlády x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x účinností xx 8.3.2018
242/2018 Xx., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 25.10.2018
184/2021 Xx., xxxxxx xx xxxx nařízení xxxxx č. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx látek, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 3.6.2021
159/2022 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.7.2022
228/2023 Sb., xxxxxx xx mění xxxxxxxx xxxxx č. 463/2013 Xx., o xxxxxxxxx návykových xxxxx, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Xx., kterým xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., o seznamech xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx xx mění xxxxxxxx vlády x. 463/2013 Sb., o xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.7.2024 x 1.1.2025
419/2024 Xx., kterým xx xxxx nařízení xxxxx x. 463/2013 Xx., x seznamech návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x účinností xx 1.1.2025 a 1.4.2025
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx předpisu.
1) Jednotná xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxx pod č. 47/1965 Sb., xx xxxxx Xxxxxxxxx x xxxxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
2) Xxxxxx x xxxxxxxxxxxxxx látkách, xxxxxxxxx xxx č. 62/1989 Sb.